PhaseBio Pharmaceuticals, Inc. (PHAS)
Working Capital Ratio
-59.17%
Quarterly · Period ending:
PHAS Working Capital Ratio
Latest reported-59.17%period ending
Latest reported-59.17%period ending
PHAS Quarterly Working Capital Ratio (-27.30% → -59.17%)
Quarterly working capital ratio
High-resolution chart · PNG
PHAS working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| -59.1672% | |
| 15.2105% | |
| 34.5243% | |
| 56.3319% | |
| 71.8682% | |
| 70.9069% | |
| 50.0209% | |
| 66.2773% | |
| 64.8764% | |
| 84.6314% | |
| 85.2717% | |
| 89.7962% | |
| 91.4951% | |
| 89.1675% | |
| 92.1064% | |
| 62.8638% | |
| 79.548% | |
| -27.2998% |